Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 20860535)

1.

Suppression of HIV replication by antiretroviral therapy reduces TIM-3 expression on HIV-specific CD8(+) T cells.

Kassu A, Marcus RA, D'Souza MB, Kelly-McKnight EA, Palmer BE.

AIDS Res Hum Retroviruses. 2011 Jan;27(1):1-3. doi: 10.1089/aid.2010.0156. Epub 2010 Sep 23. No abstract available.

PMID:
20860535
2.

Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.

López M, Soriano V, Rallón N, Cascajero A, González-Lahoz J, Benito JM.

Eur J Immunol. 2008 Jun;38(6):1548-58. doi: 10.1002/eji.200738054.

PMID:
18421792
3.

Human immunodeficiency virus type I-specific CD8+ T cell subset abnormalities in chronic infection persist through effective antiretroviral therapy.

Pohling J, Zipperlen K, Hollett NA, Gallant ME, Grant MD.

BMC Infect Dis. 2010 May 25;10:129. doi: 10.1186/1471-2334-10-129.

4.

HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.

Steel A, Cox AE, Shamji MH, John L, Nelson M, Henderson DC, Gotch FM, Gazzard BG, Kelleher P.

Antivir Ther. 2007;12(6):971-5.

PMID:
17926652
5.

An IL-15 dependent CD8 T cell response to selected HIV epitopes is related to viral control in early-treated HIV-infected subjects.

D'Offizi G, Gioia C, Corpolongo A, Martini F, Paganelli R, Volpi I, Sacchi A, Tozzi V, Narciso P, Poccia F.

Int J Immunopathol Pharmacol. 2007 Jul-Sep;20(3):473-85.

PMID:
17880761
6.

Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups.

Mollet L, Li TS, Samri A, Tournay C, Tubiana R, Calvez V, Debré P, Katlama C, Autran B.

J Immunol. 2000 Aug 1;165(3):1692-704.

7.

CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy.

Benito JM, López M, Lozano S, Martinez P, González-Lahoz J, Soriano V.

AIDS Res Hum Retroviruses. 2004 Feb;20(2):227-33.

PMID:
15018711
8.

Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV.

Boutboul F, Puthier D, Appay V, Pellé O, Ait-Mohand H, Combadière B, Carcelain G, Katlama C, Rowland-Jones SL, Debré P, Nguyen C, Autran B.

AIDS. 2005 Nov 18;19(17):1981-6.

PMID:
16260904
10.

Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia. The Master Group.

Clerici M, Seminari E, Suter F, Castelli F, Pan A, Biasin M, Colombo F, Trabattoni D, Maggiolo F, Carosi G, Maserati R.

AIDS. 2000 Jan 28;14(2):109-16.

PMID:
10708280
11.

Highly active antiretroviral therapy results in HIV type 1 suppression in lymph nodes, increased pools of naive T cells, decreased pools of activated T cells, and diminished frequencies of peripheral activated HIV type 1-specific CD8+ T cells.

Gray CM, Lawrence J, Ranheim EA, Vierra M, Zupancic M, Winters M, Altman J, Montoya J, Zolopa A, Schapiro J, Haase AT, Merigan TC.

AIDS Res Hum Retroviruses. 2000 Sep 20;16(14):1357-69.

PMID:
11018855
12.

Impact of suppression of viral replication by highly active antiretroviral therapy on immune function and phenotype in chronic HIV-1 infection.

Lange CG, Lederman MM, Madero JS, Medvik K, Asaad R, Pacheko C, Carranza C, Valdez H.

J Acquir Immune Defic Syndr. 2002 May 1;30(1):33-40.

PMID:
12048361
13.

CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation.

Benito JM, Lopez M, Lozano S, Ballesteros C, Capa L, Martinez P, Gonzalez-Lahoz J, Soriano V.

J Infect Dis. 2005 Dec 15;192(12):2142-6.

14.
17.

Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.

Al-Harthi L, Siegel J, Spritzler J, Pottage J, Agnoli M, Landay A.

AIDS. 2000 May 5;14(7):761-70.

PMID:
10839583
18.

AIDS. Boosting immunity to HIV--can the virus help?

Autran B, Carcelain G.

Science. 2000 Nov 3;290(5493):946-9. No abstract available.

PMID:
11184735
19.

Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.

Plana M, García F, Gallart T, Tortajada C, Soriano A, Palou E, Maleno MJ, Barceló JJ, Vidal C, Cruceta A, Miró JM, Gatell JM.

AIDS. 2000 Sep 8;14(13):1921-33.

PMID:
10997396
20.

Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication.

Alatrakchi N, Duvivier C, Costagliola D, Samri A, Marcelin AG, Kamkamidze G, Astriti M, Agher R, Calvez V, Autran B, Katlama C.

AIDS. 2005 Jan 3;19(1):25-33.

PMID:
15627030
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk